Latest Regulatory Milestones News

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

Alkane Resources has secured key regulatory approvals from FIRB and ASIC, paving the way for its planned merger with Mandalay Resources. This milestone brings the companies closer to creating a diversified Australian gold and antimony producer.

Neuren Pharmaceuticals has been granted a US patent for NNZ-2591 to treat Pitt Hopkins syndrome, bolstered by promising Phase 2 clinical trial results and FDA orphan drug status.

Findi Limited has secured a perpetual White Label ATM licence from the Reserve Bank of India, removing renewal hurdles and deployment limits. This milestone positions Findi to accelerate its digital financial services expansion across India’s underbanked regions.

Chalice Mining confirms its Gonneville Project Pre-Feasibility Study remains on track for Q4 2025, with environmental approvals progressing smoothly toward a late 2027 Final Investment Decision. The project’s staged open-pit design and innovative infrastructure plans underscore its strategic importance in critical minerals supply.

Astron Corporation has received the Victorian Government's final regulatory green light for its Donald Rare Earths and Mineral Sands Project, paving the way for construction and financing. This milestone advances a strategically vital project aimed at supplying critical minerals for clean energy and defense.

New World Resources has secured a crucial environmental permit for its Antler Copper Project in Arizona, accelerating its path toward construction. This milestone reflects strong state support and positions the company to begin building later in 2025.

Cyprium Metals has obtained crucial environmental and operational approvals to advance the phased redevelopment of its Nifty Copper Complex, setting the stage for a near-term production restart.

Alara Resources reports compelling copper assay results from its Block 8 concession in Oman, with Power Metal Resources advancing its stake and exploration activities moving towards drilling.

Envirosuite has secured a key regulatory green light from FIRB for its acquisition by Ideagen, moving the proposed Scheme of Arrangement closer to shareholder approval.

PYC Therapeutics has gained FDA alignment on the design of its pivotal Phase 2/3 trial for VP-001, a promising treatment for the rare childhood blindness RP11. The regulator accepted the trial’s sham control arm and primary endpoints, setting the stage for a critical next step toward drug approval.